T2750
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for T2750, covering 2014-10-27 to 2014-10-27. Get the full timeline:
Most recent: Clinical Trial Update: Comparison of the Efficacy and Safety of T2750 and Vismed® in the Treatment of Moderate to Severe Dry Eye Syndrome [Phase 3]